Product Development and Introduction is a critical end-end value stream for most life science companies, particularly for those that have put R&D and Innovation at the heart of their business strategy.
BSM specialises in helping pharmaceutical, medical device and bio-pharmaceutical organisations to re-engineer their R&D and New Product Development processes to significantly and sustainably reduce time to market and improve commercial success. We routinely employ the following best practice in consulting assignments:
- Phase Review Product Development Model
- Portfolio Management
- Concurrent Engineering
- Design for Manufacture / Assembly / Test / Packaging
- Failure Mode Effect Analysis (FMEA)
- Matrix Structure & Cross-functional teams
- Project Management
- Performance Metrics and Display.
BSM believes in:
- Implementing a new / re-engineered process that is appropriate to the type of product development being undertaken (i.e. a streamlined process for low risk products; a more extensive process for high risk projects).
- Killing new product projects when they don’t meet evaluation criteria.
- Pro-active management of idea generation.
- Having an organisation structure that is designed to support new products.
- Deploying new product project teams that are truly cross-functional.
- Project teams having full responsibility for the project through to market launch and post launch review.
